| 12297185 |
Crystalline form of tegavivint, method of preparation, and use thereof |
Gowri Sukumar |
2025-05-13 |
| 12208166 |
Lyophilized formulations of tegavivint |
Gowri Sukumar |
2025-01-28 |
| 11992470 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2024-05-28 |
| 11964054 |
Formulations of tegavivint |
Gowri Sukumar |
2024-04-23 |
| 11793759 |
Lyophilized formulations of tegavivint |
Gowri Sukumar |
2023-10-24 |
| 11672863 |
Enhanced solubility drug-containing formulations |
Michael Laird Hurrey, Peter Noymer |
2023-06-13 |
| 11602501 |
Lyophilized formulations of tegavivint |
Gowri Sukumar |
2023-03-14 |
| 11571388 |
Lyophilized formulations of tegavivint |
Gowri Sukumar |
2023-02-07 |
| 11344516 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2022-05-31 |
| 11136307 |
Crystalline form of tegavivint, method of preparation, and use thereof |
Gowri Sukumar |
2021-10-05 |
| 11000490 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2021-05-11 |
| 10772853 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2020-09-15 |
| 10765649 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2020-09-08 |
| 10493047 |
Stable aqueous capsaicin injectable formulations and medical uses thereof |
Gary Musso |
2019-12-03 |
| 6645961 |
Dry granulation formulation for an HIV protease inhibitor |
Chung Y. Lui, Ashok Katdare, Christine Stelmach |
2003-11-11 |
| 6008207 |
Anhydrous alendronate monosodium salt formulations |
Gerald S. Brenner, Earl R. Oberholtzer, Jr., J. Eric Thies |
1999-12-28 |
| 5849726 |
Anhydrous alendronate monosodium salt formulations |
Gerald S. Brenner, Earl R. Oberholtzer, Jr., J. Eric Thies |
1998-12-15 |
